News
Videos
Conferences
Events
Resources
Subscribe

|Videos|October 1, 2015

Your BRCA Gene Test Results

Episodes in this series

EP. 1 Family History of Breast Cancer

EP. 1 Family History of Breast Cancer

EP. 2 Who Needs Genetic Testing?

EP. 2 Who Needs Genetic Testing?

EP. 3 Preparing for Your BRCA Testing

EP. 3 Preparing for Your BRCA Testing

EP. 4 The Genetic Counseling Visit

EP. 4 The Genetic Counseling Visit

EP. 5 Your BRCA Gene Test Results

EP. 5 Your BRCA Gene Test Results

EP. 6 Options for Women with a BRCA Mutation

EP. 6 Options for Women with a BRCA Mutation

EP. 7 BRCA Testing for Men

EP. 7 BRCA Testing for Men

EP. 8 Myths About Risk of Familial Breast Cancer

EP. 8 Myths About Risk of Familial Breast Cancer

Newsletter

Stay up to date on cancer updates, research and education

Related Content

image of Fda.

FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer

November 13th 2025

Bonnie Annis

When One Blood Draw Could Tell More: A Look at the Cancerguard Test

November 13th 2025

After her own breast cancer treatment, Maureen advocated for legislation to make scalp cooling more accessible for patients seeking to preserve their hair.

Breast Cancer Survivor Advocates for Access to Scalp Cooling

ByMaureen Green

November 12th 2025

For Maureen Green, scalp cooling was a crucial part of her breast cancer treatment journey, as it prevented chemotherapy-induced hair loss.

Scalp Cooling Can Prevent Hair Loss During Chemo for Breast Cancer

November 12th 2025

Image of woman.

Dealing With Peripheral Neuropathy After Breast Cancer Treatment

ByCynthia Malaran

November 12th 2025

Trending on CURE

FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer

FDA Approves Komzifti for NPM1-Mutant Acute Myeloid Leukemia

Cancer Experts Share Emerging Treatments Patients Should Know in 2026

FDA Grants Drug Designation to Tinostamustine for Malignant Glioma

Shared Loss Leads to Lifelong Friendship in Rare Cancer Caregiving

© 2025 MJH Life Sciences^®

All rights reserved.